scholarly journals Uptake of Human Papillomavirus Vaccine Among Adolescent Males and Females: Immunization Information System Sentinel Sites, 2009–2012

2014 ◽  
Vol 14 (5) ◽  
pp. 497-504 ◽  
Author(s):  
Karen A. Cullen ◽  
Shannon Stokley ◽  
Lauri E. Markowitz
Keyword(s):  
Information System ◽  
Human Papillomavirus ◽  
Adolescent Males ◽  
Human Papillomavirus Vaccine ◽  
Immunization Information System ◽  
Males And Females ◽  
Papillomavirus Vaccine

A Case of Myopericarditis and the HPV vaccine

2021 ◽  
Vol 9 (12) ◽  
Author(s):  
Angela Pegram ◽  
Tara Bush
Keyword(s):  
Human Papillomavirus ◽  
Social History ◽  
Hpv Vaccine ◽  
Package Insert ◽  
Human Papillomavirus Vaccine ◽  
T Wave ◽  
Dose Number ◽  
Males And Females ◽  
Artery Disease ◽  
Papillomavirus Vaccine

Introduction: Human Papillomavirus (HPV) is the underlying etiology of numerous cancers and genital warts in both males and females. Vaccines were developed against HPV to prevent transmission and arrest development of cancers caused by the virus. Gardasil 9â is the newest vaccine, covering 9 serotypes of HPV and is recommended by the CDC for both males and females over 9 years of age in a series of vaccinations. Myopericarditis (including myocarditis and pericarditis) is not reported as an adverse reaction in the Gardasil 9â package insert. Case Report A healthy 18-year-old male with no significant past medical or social history received dose number 3 of HPV vaccine at his physician’s office. Within 24 hours, he developed chills and a fever (normal HPV reactions) and then recovered without sequelae within 48 hours. Three days later, he developed crushing chest pain, with arm tingling and jaw pain. He was triaged directly to the emergency room where he had troponins of greater than 11000 and T wave inversions on his EKG. Other diagnostic tests and labs showed normal heart anatomy and no early coronary artery disease. He was diagnosed with myopericarditis by cardiology. He was treated and recovered fully within 3 months. Discussion Using the WHO tool for adverse vaccine reactions, this case has a consistent causal relationship with vaccination. This is the eleventh case of myopericarditis reported to the Vaccine Adverse Effects Reporting system for the HPV vaccine. Conclusion Although rare, myopericarditis should be considered as a possible adverse effect from the human papillomavirus vaccine.

scholarly journals Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States

Cancer ◽  
2014 ◽  
Vol 120 (20) ◽  
pp. 3200-3207 ◽  
Author(s):  
Paul L. Reiter ◽  
Noel T. Brewer ◽  
Melissa B. Gilkey ◽  
Mira L. Katz ◽  
Electra D. Paskett ◽  
...  
Keyword(s):  
United States ◽  
Human Papillomavirus ◽  
The United States ◽  
Adolescent Males ◽  
Human Papillomavirus Vaccine ◽  
Early Adoption ◽  
Papillomavirus Vaccine

Sociodemographic Differences in Human Papillomavirus Vaccine Initiation by Adolescent Males

2015 ◽  
Vol 57 (5) ◽  
pp. 506-514 ◽  
Author(s):  
Atu Agawu ◽  
Alison M. Buttenheim ◽  
Lynne Taylor ◽  
Lihai Song ◽  
Alexander G. Fiks ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Adolescent Males ◽  
Human Papillomavirus Vaccine ◽  
Sociodemographic Differences ◽  
Vaccine Initiation ◽  
Papillomavirus Vaccine

Disparities in Human Papillomavirus Vaccine Series Completion by Adolescent Males: A Retrospective Cohort Study

2020 ◽  
Vol 20 (3) ◽  
pp. 364-373
Author(s):  
Atu Agawu ◽  
Alexandra L. Hanlon ◽  
Alison M. Buttenheim ◽  
Lihai Song ◽  
Alexander G. Fiks ◽  
...  
Keyword(s):  
Cohort Study ◽  
Human Papillomavirus ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Adolescent Males ◽  
Human Papillomavirus Vaccine ◽  
Series Completion ◽  
Papillomavirus Vaccine

Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population: What Is the Verdict Now?

2017 ◽  
Vol 56 (7) ◽  
pp. 605-615
Author(s):  
Aubrey N. Jones ◽  
Jenna W. Bartlett ◽  
Rebecca A. Bates ◽  
Tsz-Yin So
Keyword(s):  
Human Papillomavirus ◽  
Pediatric Population ◽  
World Health ◽  
Human Papillomavirus Vaccine ◽  
Older Children ◽  
Control And Prevention ◽  
Prospective Trials ◽  
Males And Females ◽  
Health Organization ◽  
Papillomavirus Vaccine

The safety and efficacy of a 2-dose series for the human papillomavirus vaccines rather than a 3-dose series in older children has not been well defined. This article reviews the literature summarizing the use of all 3 HPV vaccines (2vHPV, 4vHPV, 9vHPV) as a 2-dose series for females and 4vHPV and 9vHPV for males younger than 15 years. Six prospective trials evaluating immunogenicity of a 2-dose series of 2vHPV and/or 4vHPV, as well as an ongoing prospective clinical trial for 9vHPV, are discussed. The 2-dose series with Gardasil 9® in both males and females ages 9 to 14 years appears to be the most widely accepted recommendation. The exact time schedule between the 2 vaccines varies among studies, but it seems that they should be separated by 6 to 12 months. Federal and world-wide organizations’ (ie, Centers for Disease Control and Prevention, Food and Drug Administration, and World Health Organization) opinions and recommendations on the appropriate scheduling of the vaccines are also highlighted.

Vaccine Hesitancy and Differential Susceptibility to Media Coverage: A Critical Documentary Led to Substantial Reductions in Human Papillomavirus Vaccine Uptake in Denmark

2021 ◽  
pp. 0272989X2110035
Author(s):  
Maria Knoth Humlum ◽  
Niels Skipper ◽  
Peter Rønø Thingholm
Keyword(s):  
Human Papillomavirus ◽  
Hpv Vaccine ◽  
Media Coverage ◽  
Differential Susceptibility ◽  
Vaccine Uptake ◽  
Vaccine Hesitancy ◽  
Human Papillomavirus Vaccine ◽  
Policy Makers ◽  
Quasi Experimental ◽  
Papillomavirus Vaccine

Objectives To investigate whether negative media coverage of the human papillomavirus (HPV) vaccine led to a decrease in the uptake of the first dose of the HPV vaccine (HPV1) in Denmark and, importantly, whether some groups of individuals were more susceptible to negative media coverage. Methods We measured HPV vaccine uptake of 12-year-old girls born in 2001 to 2004 using Danish administrative data. A quasi-experimental design was employed to assess whether a documentary that was critical of the HPV vaccine and aired in March 2015 affected HPV uptake. Results The documentary led to a quick and substantial decrease in the monthly propensity to vaccinate, which dropped 3 percentage points—or about 50%—in response to the documentary. Responses differed substantially across subgroups, and girls from families with high socioeconomic status (SES) were more susceptible to the negative media coverage. Conclusions Susceptibility to negative media coverage varied substantially across subgroups, highlighting the need for policy makers to appropriately target and differentiate initiatives to improve vaccine compliance rates.

Sign in / Sign up

Export Citation Format

Share Document